Clinical Trial Update: Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease [NA]

View source ↗

Summary

The trial evaluating a medium chain fatty acid rich milk powder for infants with cholestatic liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Disease

Drugs mentioned

• Medium chain fatty acid rich milk powder (Medium chain fatty acid rich milk powder)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Cholestatic Liver Disease | NA | Status: WITHDRAWN